Esperion Therapeutics Inc ESPR:NASDAQ

Last Price$6.47NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$5.10 (4)
Ask (Size)$6.90 (4)
Day Low / HighN/A - N/A
Volume1.2 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/24/2022


Esperion Therapeutics Inc ( NASDAQ )

Price: $6.47
Change: +0.18 (2.86%)
Volume: 1.2 M
4:00PM ET 6/24/2022

Karyopharm Therapeutics Inc ( NASDAQ )

Price: $5.17
Change: +0.04 (0.78%)
Volume: 2.5 M
4:00PM ET 6/24/2022

22nd Century Group Inc ( NASDAQ )

Price: $2.42
Change: -0.15 (5.84%)
Volume: 7.3 M
4:00PM ET 6/24/2022

ADMA Biologics Inc ( NASDAQ )

Price: $1.94
Change: -0.13 (6.28%)
Volume: 26.2 M
4:00PM ET 6/24/2022

MiMedx Group Inc ( NASDAQ )

Price: $3.83
Change: -0.25 (6.13%)
Volume: 2.6 M
4:00PM ET 6/24/2022

Read more news Recent News

--JPMorgan Upgrades Esperion Therapeutics to Neutral From Underweight; Price Target is $6
5:52AM ET 5/05/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (ESPR) ESPERION THERAPEUTICS Reports Q1 Loss $-0.93, vs. Street Est of $-1.04
7:06AM ET 5/03/2022 MT Newswires


-- Earnings Flash (ESPR) ESPERION THERAPEUTICS Posts Q1 Revenue $18.8M, vs. Street Est of $15.4M
7:06AM ET 5/03/2022 MT Newswires


Esperion Therapeutics Files $400 Million Mixed Shelf
3:11AM ET 4/18/2022 MT Newswires

Esperion Therapeutics (ESPR) on Friday filed a shelf registration statement for the potential sale of up to $400 million of its securities from time to...

View all Commentary and Analysis

Enanta Pharmaceuticals (ENTA) Stock Jumps 10.1%: Will It Continue to Soar?
8:03AM ET 6/24/2022 Zacks

Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading...

Esperion Therapeutics (ESPR) Investor Presentation - Slideshow
2:12PM ET 5/26/2022 Seeking Alpha

Esperion Therapeutics: 2021 Labors Paying Off In 2022
12:03AM ET 5/07/2022 Seeking Alpha

Esperion Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation
3:06PM ET 5/03/2022 Seeking Alpha

Company Profile

Business DescriptionEsperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI. View company web site for more details
Address3891 Ranchero Drive
Ann Arbor, Michigan 48108
Number of Employees76
Recent SEC Filing06/21/20224
President, Chief Executive Officer & DirectorSheldon L. Koenig
Chief Technical Operations OfficerKen Fiorelli
Chief Medical OfficerJoAnne Micale Foody
Senior Vice President-Clinical DevelopmentWilliam J. Sasiela

Company Highlights

Price Open$6.38
Previous Close$6.29
52 Week Range$3.28 - 23.75
Market Capitalization$407.6 M
Shares Outstanding63.0 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/02/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$6.99
Beta vs. S&P 500N/A
Net Profit Margin-263.04%
Return on Equity84.42%

Analyst Ratings as of 05/03/2022

Consensus RecommendationConsensus Icon
Powered by Factset